Skip to content

Regentys

The first non-surgical treatment option for Ulcerative Colitis.

From
Miami, FL

Founded
2013

Cohort Year: Y1 (2015)
Status: Active
HQ: Miami, FL

Y1 (2015) Life Sciences

REGENTYS™ is a development-stage, regenerative medicine company focused on developing treatments for patients with gastrointestinal (GI) disorders. Our first product, ExtraCellular Matrix Hydrogel (ECMH), is a first-in-class, non-pharmacologic, non-surgical treatment option for patients suffering from Ulcerative Colitis.

Regentys Pitch at 43North Finals 2014

Founders

Richard Bulman

Other Companies